Litcius/Paper detail

Is Hydroxychloroquine a Possible Postexposure Prophylaxis Drug to Limit the Transmission to Healthcare Workers Exposed to Coronavirus Disease 2019?

Pasquale Pagliano, Ornella Piazza, Francesco De, Tiziana Ascione, Amelia Filippelli

2020Clinical Infectious Diseases24 citationsDOIOpen Access PDF

Abstract

To the Editor-We read with great interest the study by Yao et al [1] reporting that hydroxychloroquine has better antiviral activity than chloroquine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is associated 5.

Topics & Concepts

HydroxychloroquineTransmission (telecommunications)MedicineCoronavirus disease 2019 (COVID-19)CoronavirusSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyPost-exposure prophylaxisPre-exposure prophylaxisHealth careDrugLimit (mathematics)Disease2019-20 coronavirus outbreakHuman immunodeficiency virus (HIV)Infectious disease (medical specialty)PharmacologyInternal medicineOutbreakComputer scienceMathematicsMathematical analysisSyphilisTelecommunicationsEconomic growthEconomicsMen who have sex with menLong-Term Effects of COVID-19COVID-19 Clinical Research StudiesVitamin C and Antioxidants Research
Is Hydroxychloroquine a Possible Postexposure Prophylaxis Drug to Limit the Transmission to Healthcare Workers Exposed to Coronavirus Disease 2019? | Litcius